Optimising Antimicrobial Stewardship to Tackle Clostridioides difficile Infection and Improve Patient Outcomes
暂无分享,去创建一个
[1] B. Guery,et al. Treatment and Outcomes of Clostridioides difficile Infection in Switzerland: A Two-Center Retrospective Cohort Study , 2022, Journal of clinical medicine.
[2] S. Khanna,et al. Clostridioides difficile infection: curbing a difficult menace , 2022, Therapeutic advances in gastroenterology.
[3] E. Kuijper,et al. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. , 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[4] Third joint inter‐agency report on integrated analysis of consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food‐producing animals in the EU/EEA , 2021, EFSA journal. European Food Safety Authority.
[5] Y. Carmeli,et al. Antibiotic exposure and the risk of hospital-acquired diarrhoea and Clostridioides difficile infection: a cohort study. , 2021, The Journal of antimicrobial chemotherapy.
[6] E. Bouza,et al. Economic burden of recurrent Clostridioides difficile infection in adults admitted to Spanish hospitals. A multicentre retrospective observational study , 2021, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.
[7] S. Gwini,et al. The impact of infectious diseases consultation on the management and outcomes of Pseudomonas aeruginosa bacteraemia in adults: a retrospective cohort study , 2021, BMC Infectious Diseases.
[8] OUP accepted manuscript , 2021, Journal of Antimicrobial Chemotherapy.
[9] P. Thibon,et al. Effect of a prospective audit with intervention and feedback on Clostridioides difficile infection management , 2020, International Journal of Clinical Pharmacy.
[10] G. Garber,et al. Antibiotic prescribing choices and their comparative C. difficile infection risks: a longitudinal case-cohort study. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] Jeffrey P. Ferraro,et al. Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection , 2020, Antimicrobial Agents and Chemotherapy.
[12] O. Dyar,et al. Practices, organisation, and regulatory aspects in advising on antibiotic prescription: the international ESCMID AntibioLegalMap survey , 2019, Infection.
[13] David Baur,et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. , 2017, The Lancet. Infectious diseases.
[14] J. Prins,et al. Applicability of generic quality indicators for appropriate antibiotic use in daily hospital practice: a cross-sectional point-prevalence multicenter study. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[15] A. Shorr,et al. Mortality and Costs in Clostridium difficile Infection Among the Elderly in the United States , 2016, Infection Control & Hospital Epidemiology.
[16] S. Hay,et al. Antibiotic resistance is the quintessential One Health issue , 2016, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[17] D. Jenkins,et al. The impact of the introduction of fidaxomicin on the management of Clostridium difficile infection in seven NHS secondary care hospitals in England: a series of local service evaluations , 2015, European Journal of Clinical Microbiology & Infectious Diseases.
[18] M. Olsen,et al. Impact of Clostridium difficile recurrence on hospital readmissions. , 2015, American journal of infection control.
[19] M. Olsen,et al. Recurrent Clostridium difficile infection is associated with increased mortality. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[20] S. Geerlings,et al. Quality indicators to measure appropriate antibiotic use in hospitalized adults. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] E. Cordero,et al. Global impact of an educational antimicrobial stewardship programme on prescribing practice in a tertiary hospital centre. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[22] Melissa J. Krauss,et al. The value of infectious diseases consultation in Staphylococcus aureus bacteremia. , 2010, The American journal of medicine.
[23] Stephan Harbarth,et al. “Antibiotics Are Not Automatic Anymore”—The French National Campaign To Cut Antibiotic Overuse , 2009, PLoS medicine.
[24] S. Ichiyama,et al. Improved Clinical Outcome of Patients With Candida Bloodstream Infections Through Direct Consultation by Infectious Diseases Physicians in a Japanese University Hospital , 2006, Infection Control & Hospital Epidemiology.
[25] M. D. L. Rosa. Prevención de la infección perinatal por estreptococo del grupo B. Recomendaciones españolas revisadas , 2003 .
[26] J. Sbarbaro. Can we influence prescribing patterns? , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[27] H. Sax,et al. Clinical Impact of an Infectious Disease Service on the Management of Bloodstream Infection , 2000, European Journal of Clinical Microbiology and Infectious Diseases.
[28] G. Corthier,et al. Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study. , 1996, Archives of internal medicine.